<DOC>
	<DOCNO>NCT00732654</DOCNO>
	<brief_summary>The purpose study determine small oral sublingual dos milk protein safe effective decreasing sensitivity cow 's milk allergic child .</brief_summary>
	<brief_title>The Safety Efficacy Sublingual/Oral Immunotherapy Treatment Milk Protein Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Milk Hypersensitivity</mesh_term>
	<criteria>Are age 6 21 year Provide sign informed consent ( parent legal guardian subject minor ) , inform assent applicable Have history symptomatic reactivity cow 's milk ( i.e . Eczema , urticaria , upper low respiratory symptom , GI disturbance , rash oral symptom ) Have positive skin prick test ( define wheal 3 mm ≥ negative control ) cow 's milkIgE &gt; 0.35 kIU/L Have positive OFC cow 's milk cumulative dose less 184 milligram cow 's milk intact protein ( 2,400 mg total milk protein ) . Are use appropriate birth control subject female child bearing age . Have selfinjectable epinephrine ( ie . EpiPen® EpiPen Jr.® ) available home Have history severe anaphylaxis define hypoxia ( cyanosis SpO2 ≤ 92 % stage ) , hypotension , confusion , collapse , loss consciousness ; incontinence Have history intubation relate asthma Tolerate 184 milligram intact cow 's milk protein initial OFC Are pregnant lactate Have viral URI gastroenteritis within 7 day OFC ( OFC need reschedule ) Have pulmonary function test &lt; 80 % predict ( FEV1 ) clinical history consistent moderate persistent asthma Are currently take great medium dose inhale corticosteroid ( &gt; 400 mcg/day fluticasone fluticasone equivalent ≤ 12 year old &gt; 600 mcg/day &gt; 12 year old ) Are unable discontinue antihistamine 5 day long act 3 day short act prior skin test food challenge Have use systemic corticosteroid within 4 week prior baseline visit Are receive omalizumab , betablocker , ACE inhibitor tricyclic antidepressant therapy Have chronic disease ( asthma , atopic dermatitis rhinitis ) require therapy ( e.g. , heart disease , diabetes ) Have participate interventional study treatment food allergy past 12 month Have severe reaction initial DBPCFC , define either : Lifethreatening anaphylaxis , Reaction require hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Food Allergy</keyword>
	<keyword>Oral Immunotherapy</keyword>
	<keyword>Immunoglobulin E</keyword>
</DOC>